Literature DB >> 20367453

Spectrum of childhood Epstein-Barr virus-associated T-cell proliferations and bone marrow findings.

Deborah W Sevilla1, Nader Kim El-Mallawany, Foxwell N Emmons, Suzy Alexander, Govind Bhagat, Bachir Alobeid.   

Abstract

Systemic Epstein-Barr virus-positive (EBV+) T-cell lymphoproliferative disorder of childhood is a recently described entity. The majority of such cases have been reported from Asia, which suggests an underlying genetic predisposition. We analyzed the clinicopathologic characteristics of 5 children with EBV+ T-cell lymphoid proliferations evaluated and treated at our institute over a 2-year period. There were 3 males and 2 females of Latino (n  =  4) or Caucasian (n  =  1) heritage with a median age of 5 years (age range 2-18 years). All patients presented with EBV infection (acute, n  =  4) with elevated serum EBV viral loads at the time of diagnosis and had systemic manifestations, including fever, hepatosplenomegaly, and pancytopenia. The bone marrow biopsies showed EBV+/CD8+ T-cell lymphocytosis in all patients, with variable degrees of histiocytosis, plasmacytosis, and hemophagocytosis. Interestingly, there was marked and consistent depletion of mature and precursor B cells in the marrow (<1% of total marrow cellularity) in all patients. Three of the patients died of disease-associated complications 2 to 12 weeks after initial diagnosis. Our study describes the detailed bone marrow findings, contributes to the growing number of cases of systemic EBV+ T-cell lymphoproliferative disorder of childhood occurring in the Western hemisphere, and documents this disorder in patients from the Caribbean countries.

Entities:  

Mesh:

Year:  2010        PMID: 20367453     DOI: 10.2350/09-12-0753-OA.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  1 in total

1.  Comparison of the severity of cytopenias with etiologic factors in patients with pancytopenia and bicytopenia.

Authors:  Hakan Sarbay
Journal:  Pan Afr Med J       Date:  2019-11-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.